CONNECT WITH US
Web3 & Blockchain

Web3 & Blockchain

Hims & Hers Health (HIMS) Stock Price Prediction: Oversold bounce attempt meets a still-bearish trend

Blockchain.News logo

Published on

Add as a preferred source on Google
Hims  &  Hers Health (HIMS) Stock Price Prediction: Oversold bounce attempt meets a still-bearish trend

Hims & Hers Health (HIMS) is trading at $17.37 after a 1.98% drop over the last 24 hours, with momentum still weak even as Binance Futures positioning shows buyers leaning in. The stock is below it...

Hims & Hers Health (HIMS) closed the latest session at $17.37, down 1.98% on the day, and traded between $18.34 and $17.04 over the last 24 hours. That leaves the stock below its 7-day, 20-day and 50-day simple moving averages, a bearish alignment that usually signals the dominant trend is still down. The current price is also well under the 20-day mean of $22.27 and the 50-day average of $26.28, so any rebound has to prove it can do more than just snap back from oversold conditions.

The daily RSI of 27.95 puts HIMS in oversold territory, while the stochastic readings are pinned low at 3.56 for %K and 2.85 for %D. That tells you downside momentum has been extended. The catch is that the MACD remains bearish at -2.6827, with the signal line matching it and the histogram at 0.0000, so there is no clean momentum flip yet.

Bollinger positioning adds the same message from a different angle: HIMS is trading near the lower band at $14.87, with %B at 0.1687. In plain terms, the stock is stretched toward the lower edge of its recent range, but it has not shown the kind of trend reversal confirmation that would make that stretch immediately actionable.

58. HIMS is below that level, which leaves the near-term tape vulnerable unless buyers can reclaim it quickly.


Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.